Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first-line treatment for patients harboring EGFR mutations.
Predictors of hypertension control in a diverse general cardiology practice.
Waiting Lists
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.
Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?
Targeted agents in non-small cell lung cancer therapy: What is there on the horizon? J Carcinog. 2013; 12:7.
View in:
PubMed
authors with profiles
Ravi Salgia